CDMO Formex, formerly PharmaForm, has hired Steve Massah as President and CEO. Massah joins Formex from Gilead, where he worked in Strategic Drug Product Manufacturing and Outsourcing. He has previously held management positions with Avanir, ISTA, and Neurocrine Biosciences.
Formex Chairman Masood Tayebi commented, “Steve brings a wealth of knowledge and expertise in product development, operations, and manufacturing for both clinical and commercial products to Formex. We are extremely pleased to have Steve join Formex as President and CEO. Steve is well prepared to lead Formex as we continue to grow and expand in our capabilities and market presence.”
According to his LinkedIn profile, former Formex President and CEO Rudy Emmelot is now Executive VP of Bridgewest Business Group, which includes Formex parent Biotech Investment Group in its portfolio. Masood Tayebi is a partner in Bridgewest, which is chaired by his brother Massih Tayebi.
Read the Formex press release.
